All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
APPLIED THERAPEUTICS INC. Last Reported: 10/31/2021 Stock Symbol: APLT

Business Address

545 5TH AVENUE, SUITE 1400

NEW YORK, NY US 10017

Mailing Address

545 5TH AVENUE, SUITE 1400

NEW YORK, NY US 10017
Phone Number: 212-220-9319 / State Incorporated: DE / Fiscal Year End 12/31

Balance Sheet

Date 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 6/30/2018 3/31/2018 12/31/2017 12/31/2016
Cash and Cash Equivalents $70,207,000.00 $78,434,000.00 $84,067,000.00 $57,466,000.00 $48,679,000.00 $100,854,000.00 $92,503,000.00 $18,850,000.00 $13,065,000.00 $41,076,000.00 $14,686,000.00 $18,748,000.00 -- -- -- $3,277,000.00 --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $8,141,000.00 $9,634,000.00 $6,347,000.00 $5,764,000.00 $6,380,000.00 $10,026,000.00 $9,432,000.00 $7,301,000.00 $4,080,000.00 $5,708,000.00 $2,186,000.00 $1,498,000.00 -- -- -- $9,000.00 --
Total Current Assets $116,943,000.00 $135,250,000.00 $154,406,000.00 $102,593,000.00 $122,885,000.00 $148,524,000.00 $163,741,000.00 $46,155,000.00 $37,034,000.00 $46,784,000.00 $16,872,000.00 $20,246,000.00 -- -- -- $3,286,000.00 --
Property Plant and Equipement -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets -- -- -- -- -- -- -- -- $230,000.00 -- -- -- -- -- -- -- --
Total Assets $118,547,000.00 $136,959,000.00 $156,219,000.00 $104,506,000.00 $124,838,000.00 $150,572,000.00 $165,882,000.00 $48,389,000.00 $37,264,000.00 $46,784,000.00 $16,872,000.00 $20,246,000.00 -- -- -- $3,286,000.00 --
Accounts Payable $9,170,000.00 $3,310,000.00 $3,475,000.00 $640,000.00 $1,945,000.00 $5,649,000.00 $1,606,000.00 $8,793,000.00 $1,688,000.00 $3,987,000.00 $2,649,000.00 $3,015,000.00 -- -- -- $713,000.00 --
Accrued Liabilities -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Current Liabilities $31,846,000.00 $24,519,000.00 $20,998,000.00 $22,567,000.00 $21,898,000.00 $20,368,000.00 $10,054,000.00 $15,782,000.00 $6,517,000.00 $6,780,000.00 $6,328,000.00 $4,428,000.00 -- -- -- $993,000.00 --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss $-254,000.00 $-185,000.00 $-154,000.00 $-112,000.00 $-94,000.00 $-29,000.00 $89,000.00 $-2,000.00 $11,000.00 -- -- -- -- -- -- -- --
Accumulated Deficit $-239,156,000.00 $-210,738,000.00 $-184,910,000.00 $-160,731,000.00 $-137,042,000.00 $-107,198,000.00 $-79,139,000.00 $-66,770,000.00 $-49,137,000.00 $-38,424,000.00 $-29,987,000.00 $-21,257,000.00 -- -- -- $-4,736,000.00 --
Total Stockholders' Equity $86,701,000.00 $112,440,000.00 $135,221,000.00 $81,939,000.00 $102,940,000.00 $130,204,000.00 $155,828,000.00 $32,607,000.00 $30,747,000.00 $40,004,000.00 $-27,917,000.00 $-19,592,000.00 $-13,571,000.00 $-9,396,000.00 $-6,296,000.00 $-3,961,000.00 $-413,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $118,547,000.00 $136,959,000.00 $156,219,000.00 $104,506,000.00 $124,838,000.00 $150,572,000.00 $165,882,000.00 $48,389,000.00 $37,264,000.00 $46,784,000.00 $16,872,000.00 $20,246,000.00 -- -- -- $3,286,000.00 --

Statement of Operations

Date 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 6/30/2018 3/31/2018 12/31/2017 12/31/2016
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $46,846,000.00 $29,250,000.00 $14,448,000.00 $61,788,000.00 $19,945,000.00 $20,758,000.00 $7,271,000.00 $32,350,000.00 $18,582,000.00 $11,128,000.00 $6,874,000.00 $11,471,000.00 $6,111,000.00 $3,385,000.00 $1,448,000.00 $3,703,000.00 --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $78,504,000.00 $50,074,000.00 $24,199,000.00 $94,466,000.00 $70,718,000.00 $28,280,000.00 $12,467,000.00 $45,582,000.00 $27,913,000.00 $8,437,000.00 $8,729,000.00 $13,518,000.00 $3,324,000.00 $2,337,000.00 $1,868,000.00 $4,285,000.00 --
Loss from Operations $-28,430,000.00 $-50,074,000.00 $-24,199,000.00 $-94,466,000.00 $-70,718,000.00 $-40,753,000.00 $-12,467,000.00 $-45,582,000.00 $-27,913,000.00 $-17,165,000.00 $-8,729,000.00 $-13,518,000.00 $-7,529,000.00 $-4,205,000.00 $-1,868,000.00 $-4,285,000.00 --
Loss Before Income Taxes -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic $-3.08 $-1.99 -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic 25,472,590 25,114,508 -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted $-3.08 $-1.99 -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted 26,177,079 25,114,508 -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 20,441,982 20,441,982 -- -- -- 11,049,720 --
Common Stock Shares Outstanding 26,214,399 26,130,536 26,010,465 22,493,661 22,456,686 22,331,142 21,969,277 18,531,560 17,134,190 17,052,202 5,513,531 5,513,531 -- -- -- 5,458,450 --
Common Stock Value $3,000.00 $3,000.00 $3,000.00 $2,000.00 $2,000.00 $2,000.00 $2,000.00 $1,000.00 $1,000.00 $1,000.00 -- -- -- -- -- -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- $0.00 $0.00 --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 10,000,000 10,000,000 10,000,000 -- 10,000,000 10,000,000 10,000,000 10,000,000 -- -- -- -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 -- $0.00 $0.00 $0.00 $0.00 -- -- -- -- -- -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2022 PursePoor.com